MXPA01008347A - Compuestos quimicos. - Google Patents

Compuestos quimicos.

Info

Publication number
MXPA01008347A
MXPA01008347A MXPA01008347A MXPA01008347A MXPA01008347A MX PA01008347 A MXPA01008347 A MX PA01008347A MX PA01008347 A MXPA01008347 A MX PA01008347A MX PA01008347 A MXPA01008347 A MX PA01008347A MX PA01008347 A MXPA01008347 A MX PA01008347A
Authority
MX
Mexico
Prior art keywords
chemical compounds
compounds
useful
relates
present
Prior art date
Application number
MXPA01008347A
Other languages
English (en)
Inventor
Vidar Moen
Original Assignee
Norsk Hydro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro As filed Critical Norsk Hydro As
Publication of MXPA01008347A publication Critical patent/MXPA01008347A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04Cyclic acetals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18Acyclic radicals, substituted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invencion se relaciona con derivados de benzaldehido que son utiles como agentes anticancer. Algunos de los compuestos de esta invencion son novedosos per se.
MXPA01008347A 1999-02-19 2000-02-18 Compuestos quimicos. MXPA01008347A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO990814A NO309305B1 (no) 1999-02-19 1999-02-19 Anvendelse av benzaldehydderivater ved fremstilling av farmasöytiske preparater for forebygging og/eller behandling av kreft, samt visse nye benzaldehydderivater
PCT/NO2000/000060 WO2000048610A1 (en) 1999-02-19 2000-02-18 Chemical compounds

Publications (1)

Publication Number Publication Date
MXPA01008347A true MXPA01008347A (es) 2004-03-10

Family

ID=19902986

Family Applications (2)

Application Number Title Priority Date Filing Date
MXPA01008346A MXPA01008346A (es) 1999-02-19 2000-02-18 Compuestos quimicos.
MXPA01008347A MXPA01008347A (es) 1999-02-19 2000-02-18 Compuestos quimicos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MXPA01008346A MXPA01008346A (es) 1999-02-19 2000-02-18 Compuestos quimicos.

Country Status (15)

Country Link
EP (2) EP1150690A1 (es)
JP (2) JP2002537264A (es)
CN (2) CN1347323A (es)
AU (2) AU2834100A (es)
BR (2) BR0008297A (es)
CA (2) CA2362306A1 (es)
CZ (2) CZ20012965A3 (es)
HU (2) HUP0105280A2 (es)
IL (2) IL144895A0 (es)
MX (2) MXPA01008346A (es)
NO (1) NO309305B1 (es)
PL (2) PL350520A1 (es)
RU (2) RU2001123035A (es)
SK (2) SK11602001A3 (es)
WO (2) WO2000048609A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4182218B2 (ja) * 2001-05-30 2008-11-19 学校法人東京理科大学 アポトーシスを誘導する新規なグルコース誘導体、その製造方法及び医薬としてのその用途
DE10261807A1 (de) * 2002-12-19 2004-07-01 Turicum Drug Development Ag Deuterierte Catecholaminderivate sowie diese Verbindungen enthaltende Arzneimittel
WO2007012650A1 (en) * 2005-07-26 2007-02-01 Nycomed Gmbh Isotopically substituted proton pump inhibitors
CN101268050B (zh) * 2005-07-26 2012-11-28 奈科明有限责任公司 同位素取代的泮托拉唑
CA2624179A1 (en) * 2005-10-06 2007-04-12 Auspex Pharmaceuticals, Inc. Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties
CN101157711B (zh) * 2007-09-28 2010-12-08 西安交通大学 一种具有抗肿瘤活性的化合物及其用途
AU2009251848A1 (en) * 2008-04-03 2009-12-03 Cognate 3, Llc Compositions and methods for immunotherapy
CN101735284B (zh) * 2008-11-24 2012-05-23 上海医药工业研究院 一种4,6-o-苄叉-d-吡喃葡萄糖的制备方法
EP3666271A1 (en) 2013-12-03 2020-06-17 Intra-Cellular Therapies, Inc. Miscrospheres comprising a plga matrix for medical use
HUE065482T2 (hu) * 2014-04-04 2024-05-28 Intra Cellular Therapies Inc Deuterált heterociklus-fúzionált gamma-karbolinok mint 5-HT2A receptorok antagonistái
JP6898072B2 (ja) * 2015-08-27 2021-07-07 秀行 佐谷 14−3−3タンパク質活性調節剤
PT3407889T (pt) 2016-03-25 2021-07-14 Intra Cellular Therapies Inc Compostos orgânicos e a sua utilização no tratamento ou prevenção de distúrbios do sistema nervoso central
EP3525763A4 (en) 2016-10-12 2020-06-17 Intra-Cellular Therapies, Inc. AMORPHE FIXED DISPERSIONS
KR20220066988A (ko) 2017-03-24 2022-05-24 인트라-셀룰라 써래피스, 인코퍼레이티드. 신규한 조성물 및 방법
AU2019328528A1 (en) 2018-08-31 2021-03-18 Intra-Cellular Therapies, Inc. Novel methods
BR112021003838A2 (pt) 2018-08-31 2021-05-18 Intra-Cellular Therapies, Inc. métodos novos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB811510A (en) * 1954-12-20 1959-04-08 Gyogyszeripari Ki New nitrogen-containing derivatives of polyhydroxy compounds and process for the preparation thereof
JPS6112623A (ja) * 1984-06-28 1986-01-21 Kaken Pharmaceut Co Ltd エンケフアリナ−ゼ阻害剤
JPS6256423A (ja) * 1985-09-06 1987-03-12 Kaken Pharmaceut Co Ltd 悪液質治療改善剤
US4874780A (en) * 1987-03-11 1989-10-17 Norsk Hydro A.S. Anticancer compounds
JPH07145191A (ja) * 1993-11-24 1995-06-06 Japan Tobacco Inc ガラクトシルホスフォネート誘導体

Also Published As

Publication number Publication date
MXPA01008346A (es) 2003-06-06
CA2362306A1 (en) 2000-08-24
NO990814D0 (no) 1999-02-19
RU2001123124A (ru) 2004-02-20
EP1150689A1 (en) 2001-11-07
AU2834200A (en) 2000-09-04
SK11612001A3 (sk) 2002-04-04
WO2000048609A1 (en) 2000-08-24
CZ20012966A3 (cs) 2002-03-13
HUP0105281A2 (hu) 2002-05-29
IL144896A0 (en) 2002-06-30
SK11602001A3 (sk) 2002-02-05
AU2834100A (en) 2000-09-04
NO309305B1 (no) 2001-01-15
CZ20012965A3 (cs) 2002-03-13
CN1347323A (zh) 2002-05-01
WO2000048610A1 (en) 2000-08-24
BR0008297A (pt) 2002-05-28
CN1347322A (zh) 2002-05-01
JP2002537263A (ja) 2002-11-05
PL350519A1 (en) 2002-12-16
IL144895A0 (en) 2002-06-30
RU2001123035A (ru) 2004-03-20
EP1150690A1 (en) 2001-11-07
PL350520A1 (en) 2002-12-16
BR0008302A (pt) 2002-08-27
CA2363670A1 (en) 2000-08-24
JP2002537264A (ja) 2002-11-05
NO990814L (no) 2000-08-21
HUP0105280A2 (hu) 2002-04-29

Similar Documents

Publication Publication Date Title
HK1068626A1 (en) Chemical compounds
MXPA01008347A (es) Compuestos quimicos.
GB9722520D0 (en) Compounds
BG106340A (en) Substituted oxoazaheterocyclyl compounds
JO2654B1 (en) Multiple aryl caroxa amides are useful as lipid - lowering agents
AU3652102A (en) Compounds and their uses
DE602004021472D1 (en) Pyrimiidinverbindungen
PL356486A1 (en) Catalysts for hydrosilylation reactions
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
IL155875A0 (en) Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor
TW200510407A (en) Novel pyrrolodihydroisoquinolines as PDE 10 inhibitors
IL149370A0 (en) 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them
MY128924A (en) Novel compounds
DE60112330D1 (en) Pyrazolopyridinderivate
MXPA04000210A (es) Conjugados quelantes mejorados.
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
SE9901077D0 (sv) Novel use
WO2003027061A3 (en) Muscarinic agonists
SE9801494D0 (sv) Novel use
UA74430C2 (uk) Похідні фенілгетероциклічних етерів як інгібітори зворотного захоплення серотоніну
YU76500A (sh) Hemijska sinzeza morfolinskih derivata
TR200200494T2 (tr) Yağlı asit sintazı inhibitörleri.
DE60201074D1 (en) Pyrazolopyridinderivate
DK1206452T3 (da) Fremgangsmåde til fremstilling af benzoperhydro-isoindolforbindelser
SE9904128D0 (sv) Novel compounds

Legal Events

Date Code Title Description
FA Abandonment or withdrawal